Ralf Bartenschlager

发表

SARS-CoV-2 nsp3 and nsp4 are minimal constituents of a pore spanning replication organelle

P. Chlanda, Zach Hensel, L. Zimmermann, 2023, Nature communications.

Glycan-directed SARS-CoV-2 inhibition by leek extract and lectins with insights into the mode-of-action of Concanavalin A.

Heeyoung Kim, Ralf Bartenschlager, Maja Klevanski, 2024, Antiviral research.

1 Challenges for targeting SARS-CoV-2 proteases as a therapeutic strategy for COVID-19

Ruth Geiss-Friedlander, M. Cortese, Brett M. Babin, 2022 .

Antiviral drug screen identiﬁes DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication

R. Damoiseaux, M. Parcells, V. Arumugaswami, 2022 .

Phosphatidylserine-exposing extracellular vesicles in body fluids are an innate defence against apoptotic mimicry viral pathogens

E. Herker, M. Cortese, U. Bunz, 2024, Nature microbiology.

Zika virus prM protein contains cholesterol binding motifs required for virus entry and assembly

I. Vattulainen, P. Lozach, Giray Enkavi, 2023, Nature communications.

Identification of host dependency factors involved in SARS-CoV-2 replication organelle formation through proteomics and ultrastructural analysis

M. Cortese, C. Neufeldt, Charlotta Funaya, 2023, Journal of virology.

Immune-mediated effects targeting hepatitis C virus in a syngeneic replicon cell transplantation mouse model

Ralf Bartenschlager, 2022 .